Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03534544 · ClinicalTrials.gov registry record

Patient and Parent Preferences for an On-Body Automated Insulin Delivery System

A clinical trial of Diabetes Mellitus, Type 1, sponsored by Joslin Diabetes Center.

Completed
Registry status
362
Enrollment target
2
Study locations

NCT03534544 is a study of Diabetes Mellitus, Type 1 that has completed, run by Joslin Diabetes Center. The registered enrollment target is 362 participants, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03534544, a study of Diabetes Mellitus, Type 1, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
362 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to learn more about patient and family preferences regarding use of advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of young persons with type 1 diabetes will complete one study visit involving a semi-structured interview and surveys. The results of the study will be used to assist in the design of a new automated insulin delivery system.

Conditions Studied

Study Locations (2)

Connecticut

  • Yale University School of Medicine - New Haven

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 362 participants
Start Date 2018-08-23
Est. Completion 2019-12-17

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT03534544

The ClinicalTrials.gov registry entry for NCT03534544 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 362 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (71% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 0 interventions.

NCT03534544 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03534544 about?

NCT03534544 is a clinical study titled "Patient and Parent Preferences for an On-Body Automated Insulin Delivery System". The goal of this study is to learn more about patient and family preferences regarding use of advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of young persons with type 1 diabetes will complete one study visit involving a semi-structured interview and surve...

What is the current status of trial NCT03534544?

This trial is currently completed. The enrollment target is 362 participants. The study started on 2018-08-23. Estimated completion is 2019-12-17.

What conditions does trial NCT03534544 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.

Who is sponsoring clinical trial NCT03534544?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03534544 being conducted?

This trial has 2 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.